14 hours ago
Cell Therapy
14 hours ago
License out/inImmunotherapyCell Therapy
14 hours ago
14 hours ago
AcquisitionLicense out/inADC
14 hours ago
Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic disease
Drug ApprovalBreakthrough TherapyClinical Result
20 Nov 2026
Immuneering Presents Additional Data Demonstrating Atebimetinib’s Broad Potential as a Backbone for Combination Therapy in Pancreatic Cancer
Clinical ResultAACR
20 Nov 2026
Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
Clinical ResultAACR
20 Nov 2026
Telomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer
INDClinical StudyLicense out/in
20 Nov 2026
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
Clinical Result
20 Nov 2026
Providence Therapeutics Enrolls First Patient in World’s First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer
VaccinemRNAClinical StudyImmunotherapy
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!